Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish
Leukemia (2013) 27, 1913-1917; doi:10.1038/leu.2013.67 PU.1 is a member of Ets-family transcription factors, which is indispensable for generating early myeloid progenitors 1 and for the determination of monocytic versus granulocytic lineages during myelopoiesis. 2, 3 Apart from its early function in myelopoiesis, PU.1 is also reported to be involved in leukemogenesis in mice and human. 4 It has been shown that PU.1 expression is downregulated in human acute myeloid leukemia (AML) patients, 5, 6 and PU.1 mutations are found in about 7% of the patients in a study involving 126 AML patients. 7 Likewise, reduction of PU.1 activity leads to AML in mice. 8, 9 Owing to its unique advantages, zebrafish has been utilized as a promising model for studying many aspects of developmental biology and human diseases. 10 Through targeting induced local lesions in genomes (TILLING) approach, we obtained a hypomorphic pu.1 zebrafish allele (pu.1 G242D ), which harbors a point mutation in the DNA binding domain of the Pu.1 protein. 3 This mutation does not affect pu.1 transcription but destabilize Pu.1 protein, resulting in a reduction of Pu.1 activity. 3 To explore the effect of the pu.1 G242D mutation on myeloid cell development of definitive origin, we first examined the expression of CCAAT/enhancer binding protein a (cebpa), an early myeloidspecific marker in larvae stage when definitive wave of Accepted article preview online 4 March 2013; advance online publication, 26 March 2013 Letters to the Editor myelopoiesis emerged. Result showed an obvious increase of myeloid cells in the caudal hematopoietic tissue (CHT), a hematopoietic tissue equivalent to the mammalian fetal liver, 11 of 3 dpf (days postfertilization) pu.1 G242D embryos (Figure 1a) . Meanwhile, the erythroid lineage is unaffected as indicated by unaltered expression of b-e1-globin (Supplementary Figure 1A) .
As the inactivation of PU.1 in adult mice leads to overproduction of granulocytic lineage cells, 12 we reasoned that the increased myeloid cells in the CHT of pu.1 G242D mutants were likely to be of granulocytic origin. To support this hypothesis, whole-mount in situ hybridization (WISH) was performed to examine the expression of granulocyte markers cebp1, myeloperoxidase (mpx) (f and h) SB staining in 3 dpf (f ) and 8 dpf (h) larvae. Red boxed regions show the enlarged CHT (f) and kidney (h) regions (20 Â ), and green boxed region showed more enlarged region (f, 100 Â ) (Fisher exact tests, Pp0.001). (g) Cy3-tyramide based detection of endogenous peroxidase activity in the CHT region of 3 dpf embryos (Fisher exact tests, P ¼ 0.008). (i-l) Whole KM blood cells (i) and PB cells (k) in 18 monthold WT and pu.1 G242D fish stained with May-Grunwald/Giemsa staining. Arrowheads, arrows, and asterisk indicate progenitors, myeloid cells and lymphocytes, respectively. Original magnification is 100 Â . Blood cell counts of KM (j) and PB (l) in WT (blue bars) and pu.1 G242D (red bars) fish were calculated manually based on their morphology. The asterisks indicate statistical difference (t-test, KM in WT n ¼ 9, PB in WT n ¼ 9, KM in pu.1 G242D n ¼ 10, PB in pu.1 G242D n ¼ 11, mean ± s.d., *Pp0.05).
and lysozyme C (lyz). As anticipated, the expression of all three granulocytic markers was elevated in the CHT of 3 dpf pu.1 G242D embryos (Figures 1b-d) . Likewise, Sudan Black B (SB) positive cells significantly enriched in the CHT of pu.1 G242D mutants (Figure 1f ). In contrast, macrophage number was reduced in pu.1 G242D embryos as indicated by the decreased expression of macrophage marker mfap4 (Figure 1e ). These observations indicate that the increased myeloid cells in pu.1 G242D mutants are granulocytic lineage. Moreover, consistent with the notion that cebp1 is predominantly expressed in immature granulocytes, 3 the increased myeloid cells are likely to be immature granulocytes as the majority of them were cebp1 þ (Figure 1b ) with faint and small SB staining (Figure 1f) . This is further supported by the finding that the activity of neutrophil-specific peroxidase was markedly reduced in pu.1 G242D mutants (Figure 1g ). From these data, we conclude that the expanded myeloid cells in pu.1 G242D mutants are immature granulocytes.
It is known that loss-of-function mutations in PU.1 or the downregulation of PU.1 expression are associated with the onset and progression of AML in humans, 5, 6 and the reduction of PU.1 activity causes AML development in mice. 8, 9 We therefore investigated whether pu.1 G242D mutant fish would develop an AML-like hematological disorder. Fortunately, pu.1 G242D mutants can survive to adulthood with relative normal size, weight, and feeding and mating manner, thus allowing us to examine the definitive blood composition of mutant fish from larvae to adulthood. As shown in Figure 1h , by 8 dpf, the expanded myeloid cells, as indicated by the SB staining, in mutant larvae Letters to the Editor were largely restricted to the kidney marrow (KM) (Figure 1h) , the adult hematopoietic organ equivalent to the mammalian bone marrow. 11 To monitor definitive blood composition, the KM and peripheral blood (PB) cells were collected from 2-, 12-and 18-month-old mutants or siblings and subjected to cytological and blood cell count analysis. Results revealed that there was a significant (B5-20%) expansion of myeloid cell number in the KM, but not in the PB in 2-and 12-month-old mutant fish (Supplementary Figure 1B-I) . By the 18 months of age, pu.1 G242D mutants displayed about 23% increase of myeloid population and B20% reduction of lymphoid population in the KM shown by manual differential blood cell counts (Figures 1i and j) . Cytological analysis revealed that the accumulated myeloid population in the pu.1 G242D KM was largely immature myeloid cells (Figure 1i) . Moreover, the immature myeloid cells were also found to accumulate in the PB of mutants (Figures 1k and i) . These defects resemble the phenotypes of myeloid dysplastic syndrome (MDS) or AML in humans.
To define that cellular mechanisms mediated the expanded myeloid cells in pu.1 G242D mutants, we monitored the cell death and proliferation of neutrophils by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and BrdU (5-bromo-2 0 -desoxyuridine) incorporation assay, respectively. Results showed that, while neutrophil apoptosis was similar between pu.1 G242D mutants and wild-type (WT) (Figures 2a-c) , BrdU incorporation was significantly increased in the pu.1 G242D mutants (Figures 2d-f ). These data indicated that the enrichment of myeloid cells in pu.1 G242D mutants resulted from increased proliferation and not from apoptosis of neutrophils.
As zebrafish recently emerged as a promising animal model for studying human diseases and for drug discovery, we reasoned that pu.1 G242D mutants might serve as a model for the development of new therapeutic strategies for MDS treatment and for prevention of AML. To provide a 'proof-ofconcept' evidence to support such notion, we evaluated whether pu.1 G242D mutants would respond to cytarabine 13 and daunorubicin 14 treatment, two common chemotherapy agents used for the treatment of AML patients to inhibit uncontrollable cell cycle and to induce apoptosis of expanded leukemic cells, respectively. Given that pu.1 G242D mutants display myeloid hyperplasia from larvae stage onwards (Figure 1) , examination of the granulocyte expansion in pu.1 G242D embryos could therefore be used to measure the response to the cytarabine and daunorubicin treatment. Mutant embryos and their siblings were incubated with 10 3 mg/l cytarabine or 30 mg/l daunorubicin at 1 dpf and the number of granulocyte lineage cells was subsequently determined by calculating the SB þ cells in the CHT at 5 dpf, as the enrichment of granulocytes in pu.1 G242D embryos is easy to visualize at this time point (Figure 2g ). As shown in Figure 2 , after cytarabine treatment for 4 days, the SB þ cells in pu.1 G242D embryos were significantly fewer in number than those in the untreated control (Figures 2h and i) , while the WT control showed insignificant difference whether treated or not (Figures  2h and i) . Interestingly, daunorubicin treatment seemed to have little effect on the number of SB þ granulocytes in pu.1 G242D mutant embryos (Figures 2h and j) . This result indicates that the antiproliferation drug cytarabine, can induce the remission of the neoplastic proliferation of myeloid cells and relief the leukemic like phenotype in pu.1 G242D mutants, whereas the apoptosispromoting drug daunorubicin fails to do so.
In sum, this study shows that in pu.1 G242D zebrafish mutants, immature myeloid cells begin to increase in the CHT, the hematopoietic tissue equivalent to the mammalian fetal liver, 11 from 3 dpf onwards. By 18 months of age, pu.1 G242D mutants display hematological phenotypes resembling human MDS and AML: the expansion of myeloid blasts in the KM and the accumulation of myeloid blasts in the PB. As PU.1 has been shown to be important for terminal maturation of neutrophils in knockout mice, 15 we anticipate that the immaturity of granulocytes in pu.1 G242D is directly caused by the reduction of Pu.1 activity. Intriguingly, pu.1 G242D fish are sensitive to antileukemia chemotherapy. Thus, pu.1 G242D mutant fish provides a valuable animal model system for in vivo drug evaluation and large-scale antineoplastic screening.
